NCT05841914View on ClinicalTrials.gov

Multicentre Implementation and Validation of a Molecular Diagnostic for VitreoRetinal Lymphoma

RecruitingOBSERVATIONAL
Enrollment

220

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2028

Conditions
Vitreoretinal Lymphoma
Trial Locations (1)

23538

RECRUITING

University Clinic of Schleswig-Holstein, Lübeck

All Listed Sponsors
collaborator

University Hospital Tuebingen

OTHER

collaborator

University Hospital Schleswig-Holstein

OTHER

lead

Vinodh Kakkassery, MD

OTHER